Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated in the MARINA and ANCHOR Trials
Author:
Funder
Genentech, Inc
Novartis Pharma
Publisher
Elsevier BV
Subject
Ophthalmology
Reference19 articles.
1. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study;Klein;Ophthalmology,1997
2. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study;Klein;Ophthalmology,2007
3. Five-year incidence of age-related maculopathy: the Visual Impairment Project;Mukesh;Ophthalmology,2004
4. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study;van Leeuwen;Arch Ophthalmol,2003
5. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration;Arch Ophthalmol,1997
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Incidence and risk factors of fellow-eyes wet conversion in unilateral neovascular age-related macular degeneration over 15-year follow-up;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-08-23
2. Choroidal imaging biomarkers as predictors of conversion to exudative age-related macular degeneration;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-08-20
3. Fellow Eyes Conversion Rates in Patients With Unilateral Exudative Age-Related Macular Degeneration: An Academy IRIS ® Registry Analysis;Ophthalmic Surgery, Lasers and Imaging Retina;2024-04
4. Exudative Progression of Treatment-Naïve Nonexudative Macular Neovascularization in Age-Related Macular Degeneration: A Systematic Review With Meta-Analyses;American Journal of Ophthalmology;2024-01
5. Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost–Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration;Ophthalmology and Therapy;2023-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3